SEC Form 4 · accession 0001209191-18-038901
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Simard
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jun 19, 2018
Accepted (ET)
Jun 21, 2018 · 3:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $4.44 | Jun 19, 2018 | A | 200,000 | A | Jun 19, 2019 | Jun 19, 2028 | Common Stock | 200,000 | 200,000 | D |
Remarks
On June 19, 2018 (the Grant Date) the reporting person was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in three equal annual installments commencing on the first anniversary of the Grant Date with an expiry of ten years from the Grant Date.